Synergy Pharma Stock Price (NASDAQ:SGYP)

Add to My Stocks
$1.69 $0.01 (0.6%) SGYP stock closing price Sep 18, 2018 (Closing)
Prev Close* : $1.68
Market Cap:
$416.62M
Day Low: $1.67
52 Week Low: $1.43
Open: $1.67
Volume: -
Day High: $1.72
52 Week High: $3.57
Dividend:
0.00

Latest Stock Market News

Latest Articles

Synergy Pharma News - From Partners

SGYP Stockcharts

View SGYP PE ratio, PS ratio stocks charts and compare with peers.
SGYP Chart
Note: Compare Synergy Pharma stock price history with the index and industry peers.

Synergy Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
11.84
PB ratio (
price to book ratio
)
-31.07

Synergy Pharma Returns

ROE
(return on equity)
-

Synergy Pharma Financial Ratios

Asset Turnover
0.43
Receivables Turnover
6.03
Debt to Equity
-
Dividend Yield
0%

SGYP Industry Peers

Company Price Change (%)
Akebia Therapeutics (AKBA)7.780.17 (2.23%)
Forty Seven Inc (FTSV)13.460.78 (5.48%)
Protagonist Thr (PTGX)8.170.34 (4%)
Seres Therapeutics (MCRB)7.410.03 (0.4%)
Progenics Pharma (PGNX)60.12 (2.04%)
Ardelyx (ARDX)3.90.05 (1.3%)
Synthetic Biologics (SYN)2.090.03 (1.46%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 18, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 18, 2018

Synergy Pharmaceuticals Inc Stock News - Partner Headlines

Synergy Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues16.82M----
Net Income-224.33M-198.6M-117.5M-95.7M-62.12M
Total Operating Expense230.2M145.28M99.81M94.27M62.31M
View Synergy Pharma income statement
balance sheet20172016201520142013
Total Assets166.6M89.85M115.92M213.34M72.55M
Total Liabilities172.12M52.31M171.14M218.5M17.21M
Shareholders Equity-5.51M37.54M-55.21M-5.15M55.34M
View Synergy Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-13M6.62M1.7M2.62M4.91M
Net Cash from (used by) Operating Activities-212.88M-129.75M-100.98M-89.06M-52.63M
Increase (Decrease) in Prop Plant And Equipment-0.21M-0.29M-0.05M-0.17M-0.61M
View Synergy Pharma cash flow statement

Synergy Pharma Stock Message Board

As of last trading day, Synergy Pharma stock price was $1.69. The total market value as denoted by $416.62M for Synergy Pharma, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Synergy Pharma valuation, even though in the short-term, sentiment and current breaking news might affect Synergy Pharma stock price.

For recognizing and analyzing the real performance of Synergy Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 1,038,307 on the last trading day, as is evident from Synergy Pharma stock chart, and SGYP stock quote data. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Synergy Pharma does not pay dividends. Synergy Pharma stock price history, gives the entire historical data for SGYP stock.